Lingyu Wei

1.3k total citations
31 papers, 955 citations indexed

About

Lingyu Wei is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Lingyu Wei has authored 31 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Immunology and 8 papers in Oncology. Recurrent topics in Lingyu Wei's work include RNA modifications and cancer (7 papers), Viral-associated cancers and disorders (5 papers) and Immune cells in cancer (5 papers). Lingyu Wei is often cited by papers focused on RNA modifications and cancer (7 papers), Viral-associated cancers and disorders (5 papers) and Immune cells in cancer (5 papers). Lingyu Wei collaborates with scholars based in China, Saudi Arabia and Ethiopia. Lingyu Wei's co-authors include Jian Ma, Jianxun Ding, Jinjin Chen, Peng Qiu, Xiang Zheng, Qun Yan, Guiyuan Li, Zailong Qin, Zhengshuo Li and Shuhua Zhao and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Oncogene.

In The Last Decade

Lingyu Wei

30 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyu Wei China 17 440 268 257 192 134 31 955
Guang‐Hong Tan China 21 525 1.2× 183 0.7× 161 0.6× 249 1.3× 102 0.8× 66 1.1k
Monica Loi Italy 19 561 1.3× 191 0.7× 150 0.6× 254 1.3× 168 1.3× 31 1.1k
Zhao Yang China 16 341 0.8× 243 0.9× 95 0.4× 148 0.8× 78 0.6× 35 907
Mohammad Doroudian Iran 25 831 1.9× 144 0.5× 365 1.4× 297 1.5× 195 1.5× 49 1.6k
Fazel Shokri Iran 16 518 1.2× 273 1.0× 76 0.3× 320 1.7× 114 0.9× 71 1.1k
Funan Liu China 20 613 1.4× 302 1.1× 158 0.6× 140 0.7× 170 1.3× 54 1.3k
Fenglei Wu China 18 520 1.2× 283 1.1× 273 1.1× 300 1.6× 175 1.3× 33 1.1k
Yun Feng China 19 640 1.5× 400 1.5× 352 1.4× 352 1.8× 39 0.3× 76 1.4k
Tianzhou Liu China 14 349 0.8× 221 0.8× 119 0.5× 219 1.1× 127 0.9× 36 865

Countries citing papers authored by Lingyu Wei

Since Specialization
Citations

This map shows the geographic impact of Lingyu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyu Wei more than expected).

Fields of papers citing papers by Lingyu Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyu Wei. The network helps show where Lingyu Wei may publish in the future.

Co-authorship network of co-authors of Lingyu Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyu Wei. A scholar is included among the top collaborators of Lingyu Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyu Wei. Lingyu Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hu, Zhengyu, Wenchao Li, Lingyu Wei, & Jian Ma. (2025). Lactoferrin in cancer: Focus on mechanisms and translational medicine. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(3). 189330–189330. 2 indexed citations
3.
Qiao, Yi, et al.. (2025). Nanoparticle-Based Strategies to Enhance the Efficacy of STING Activators in Cancer Immunotherapy. International Journal of Nanomedicine. Volume 20. 5429–5456. 3 indexed citations
4.
Li, Zhengshuo, Xiaoyue Zhang, Can Liu, et al.. (2024). Engineering a nano-drug delivery system to regulate m6A modification and enhance immunotherapy in gastric cancer. Acta Biomaterialia. 191. 412–427. 12 indexed citations
5.
Du, Bin, et al.. (2024). Unraveling the independent role of METTL3 in m6A modification and tumor progression in esophageal squamous cell carcinoma. Scientific Reports. 14(1). 15398–15398. 3 indexed citations
6.
Wei, Lingyu, et al.. (2024). Clinical diagnostic value of metagenomic next-generation sequencing in patients with acute infection in emergency department. Heliyon. 10(16). e35802–e35802. 1 indexed citations
7.
Zhang, Xiaoyue, Can Liu, Zhengshuo Li, et al.. (2023). Epstein–Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1. Journal of Biological Chemistry. 299(9). 105082–105082. 5 indexed citations
8.
Liu, Can, Peng Qiu, Lingyu Wei, et al.. (2022). Deficiency of Lactoferrin aggravates lipopolysaccharide-induced acute inflammation via recruitment macrophage in mice. BioMetals. 36(3). 549–562. 9 indexed citations
9.
Zhao, Lin, Yuanyuan Liu, Simiao Zhang, et al.. (2022). Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer. Cell Death and Disease. 13(4). 378–378. 69 indexed citations
10.
Zhang, Xiaoyue, Peishan Liu, Jia Wang, et al.. (2021). N6-methyladenosine regulates ATM expression and downstream signaling. Journal of Cancer. 12(23). 7041–7051. 6 indexed citations
11.
Li, Zhengshuo, Jing Wang, Xuemei Zhang, et al.. (2020). Proinflammatory S100A8 Induces PD-L1 Expression in Macrophages, Mediating Tumor Immune Escape. The Journal of Immunology. 204(9). 2589–2599. 34 indexed citations
12.
Zhang, Jiaxing, Xiaosi Li, Rui He, et al.. (2020). The Effectiveness of Clinical Pharmacist-Led Consultation in the Treatment of Infectious Diseases: A Prospective, Multicenter, Cohort Study. Frontiers in Pharmacology. 11. 575022–575022. 14 indexed citations
13.
Liu, Peishan, Xiaoyue Zhang, Zhengshuo Li, et al.. (2020). A significant role of transcription factors E2F in inflammation and tumorigenesis of nasopharyngeal carcinoma. Biochemical and Biophysical Research Communications. 524(4). 816–824. 16 indexed citations
14.
Jia, Xu, Zhenbo Guo, Shuhan Yang, et al.. (2020). A two-photon benzocoumarin-NBD dyad for highly selective and sensitive ratiometric detection of H2S in biological samples. Dyes and Pigments. 185. 108906–108906. 11 indexed citations
15.
Wang, Jia, Xiang Zheng, Zailong Qin, et al.. (2019). Epstein–Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer. Journal of Biological Chemistry. 294(13). 4854–4866. 42 indexed citations
16.
Qiu, Peng, Ling Chen, Jia Wang, et al.. (2018). EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer. Cell Death and Disease. 9(12). 1146–1146. 42 indexed citations
17.
Zhang, Xuemei, Lingyu Wei, Jing Wang, et al.. (2017). Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice. Frontiers in Immunology. 8. 1774–1774. 73 indexed citations
18.
Zeng, Zhen, Shuping Ding, Xue Zeng, et al.. (2017). The value of transvaginal ultrasound in clinical surgical treatment of cesarean scar pregnancy. Journal of Huazhong University of Science and Technology [Medical Sciences]. 37(4). 536–540. 6 indexed citations
19.
Wei, Lingyu, Jinjin Chen, Shuhua Zhao, Jianxun Ding, & Xuesi Chen. (2017). Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs. Acta Biomaterialia. 58. 44–53. 108 indexed citations
20.
Lu, Yuanjun, Zailong Qin, Jia Wang, et al.. (2017). Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway. Journal of Innate Immunity. 9(6). 574–586. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026